Thank you!

Your quote has been successfully submitted!

For products requiring additional information, our team will contact you within 1 business day

Failed

There was an error submitting your quote. Please try again.

MSE PRO PEG-COOH Modified Upconverting Nanoparticles Water Solution– MSE Supplies LLC

Free Shipping on MSE PRO Online Orders of $500 or More! U.S. Orders Only * Offer Excludes Hazmat Shipments *

Menu
Cart

This product has been added to the cart.

MSE PRO PEG-COOH Modified Upconverting Nanoparticles Water Solution, 10mg/bottle - MSE Supplies LLC

MSE PRO PEG-COOH Modified Upconverting Nanoparticles Water Solution, 10mg/bottle

SKU: CM8053

  • $ 1,40995
  • Save $ 17000

MSE PRO™ PEG-COOH Modified Upconverting Nanoparticles Water Solution

Applications:

Upconverting nanoparticles display great photostability and are routinely applied in diverse biomedical scenarios such as bioimaging, biological detection, immunohistochemistry, microarray detection, photodynamic therapy, and photo-controlled drug release.

Store sealed and light-protected at 4-8℃.

MSE Supplies offers a variety of quantum dots (QDs) products, include graphene oxide QDs, graphene QDs, sulfur QDs, carbon QDs, silicon QDs, etc. We can also provide powder form quantum dots. Please contact us for more information.

Specifications:

SKU# CM8053 CM8054 CM8055
Emission Wavelength 365/475nm 545/660nm 804nm
Light Type UV/Purple Green-yellow Near-infrared
Solvent Water
Composition NaYREF4 (RE: Yb, Er, Tm, Gd, Mn, Lu)
Excitation Wavelength 975-980nm
Package Size 10mg/bottle
Concentration 5-10mg/mL
Particle Size 35nm

Reference:

[1] Kedar Sahoo, Sudhir Ranjan, Manoj Kumar, Lattice-strain induced photophysical properties of NaYF4: Yb3+, Tm3+ upconverting phosphors, Journal of Luminescence, Volume 251, 2022, 119249, ISSN 0022-2313.

[2] Johyun Yoon, Xuan Thien Le, Juho Kim, Hyunjun Lee, Nguyen Thi Nguyen, Woo Tak Lee, Eun Seong Lee, Kyung Taek Oh, Han-Gon Choi, Yu Seok Youn, Macrophage-reprogramming upconverting nanoparticles for enhanced TAM-mediated antitumor therapy of hypoxic breast cancer, Journal of Controlled Release, Volume 360, 2023, Pages 482-495, ISSN 0168-3659.